Korro Bio is a biotechnology company that develops and commercializes RNA editing therapies for the treatment of liver, eye and CNS disorders. Read more

1 Followers on Owler
1 Followers on Owler
1 Followers on Owler
1 Followers on Owler

Korro Bio is a biotechnology company that develops and commercializes RNA editing therapies for the treatment of liver, eye and CNS disorders. Read more

Ram Aiyar's photo - CEO of Korro Bio

CEO

Ram Aiyar

CEO Approval Rating

90/100

Founded:

2018

Status:

PrivateIndependent Company

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

ShapeTx is perceived as one of Korro Bio's biggest rivals. ShapeTx's headquarters is in Seattle, Washington, and was founded in 2018. ShapeTx operates in the Biotechnology industry. ShapeTx generates 55% of Korro Bio's revenue.

ElevateBio has been one of Korro Bio's top competitors. ElevateBio is a Private company that was founded in 2017 in Cambridge, Massachusetts. ElevateBio operates in the Biotechnology industry. Compared to Korro Bio, ElevateBio has 44 more employees.

Wave Life Sciences is Korro Bio's #3 rival. Wave Life Sciences was founded in Cambridge, Massachusetts} in 2012. Wave Life Sciences is in the Biotechnology industry. Compared to Korro Bio, Wave Life Sciences generates $11.6M more revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 21 a good estimate for Korro Bio's Employee count?

Acquisitions

No recent acquisitions found related to Korro Bio

Korro Bio Funding History

$4M$95.5M

Since Korro Bio was founded in 2018, it has participated in 2 rounds of funding. In total Korro Bio has raised $95.5M. Korro Bio's last funding round was on Sep 2020 for a total of $91.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Sep 2020
$91.5M

Wu Capital

Seed
May 2019
$4M

Since Korro Bio was founded in 2018, it has participated in 2 rounds of funding. In total Korro Bio has raised $95.5M. Korro Bio's last funding round was on Sep 2020 for a total of $91.5M

Investments

No recent investments found related to Korro Bio

Korro Bio News

September 10, 2020The Business Journals

Biotech plans first drug trial, C-suite hiring push after $91M round

Korro Bio has more than $90 million in the bank and a lead drug candidate. What else does it need? A ... See more »
September 10, 2020STAT News

Korro Bio raises $90 million to fix mutations that cause diseases

Korro's approach to RNA editing could lead to treatments for disorders that affect the liver, eyes an... See more »
September 9, 2020Endpoints News

Animal data in hand, Nessan Bermingham banks $91.5M for Atlas-backed RNA editing play

Korro Bio, the RNA editing startup that got started on $4 million in seed funding from Atlas and some... See more »
October 7, 2019Techstartups

Gene editing startup Korro Bio launches to advance groundbreaking new approach to RNA editing

Korro Bio, a new gene editing startup new startup founded to lead the rapidly advancing field of RNA ... See more »
October 7, 2019The Business Journals

New Cambridge biotech Korro aims to develop a reversible form of gene editing

Atlas Venture has announced the launch of a new biotech startup Monday called Korro Bio, based on a t... See more »

Korro Bio Press Releases

Social Media

Headquarters

‍400 Technology Square 10th Floor

Cambridge, Massachusetts02139

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Korro Bio is a biotechnology company that develops and commercializes RNA editing therapies for the treatment of liver, eye and CNS disorders. Korro Bio was founded in 2018. Korro Bio's headquarters is located in Cambridge, Massachusetts, USA 02139. I...

CEO

Korro Bio's CEO, Ram Aiyar, currently has an approval rating of 90%. Korro Bio's primary competitors are ShapeTx, ElevateBio & Wave Life Sciences.

Website

korrobio.com

Frequently Asked Questions about Korro Bio

  1. When was Korro Bio founded?

    Korro Bio was founded in 2018
  2. Who is Korro Bio's CEO?

    Korro Bio's CEO is Ram Aiyar
  3. How much revenue does Korro Bio generate?

    Korro Bio generates $2M in revenue
  4. How much funding does Korro Bio have?

    Korro Bio has historically raised $95.5M in funding
  1. Where is Korro Bio's headquarters?

    Korro Bio's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Korro Bio have?

    Korro Bio has 21 employees
  3. What sector does Korro Bio operate in?

    Korro Bio is in Biotechnology
  4. Who are Korro Bio's competitors?

    Korro Bio's top competitors are ShapeTx, ElevateBio, Wave Life Sciences